EUVIMED · CrossrefJournal
Reumatismo
ISSN 0048-7449 · PAGEPress Publications
Latest articles
When feeling active is not enough: the gap between perceived and real-world physical activity in axial spondyloarthritis
Complement inhibition: a therapeutic turning point in the treatment of recurrent myelitis in a patient with systemic lupus erythematosus
Atypical adult polyarteritis nodosa unmasking deficiency of adenosine deaminase 2: a case report about the importance of genetic testing in adults
Delayed referral, socioeconomic status, and disease characteristics as factors associated with disabilities in rheumatoid arthritis patients: a multicenter observational study
Telerheumatology to improve first access outcomes in outpatients: a prospective monocentric pilot study
Hypocomplementemic urticarial vasculitis: a rare presentation revealing systemic lupus erythematosus and Sjögren’s disease
Is there still someone laughing at Christopher Columbus?
Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue
The Italian Society of Rheumatology clinical practice guidelines for the management of vaccines in adult patients with rheumatic diseases
Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement
PO:03:034 | Inhibition of Radiographic Progression with Bimekizumab Treatment Observed in bDMARD-Naïve Patients with Active Psoriatic Arthritis at 2 Years: Results from a Phase 3 Study and its Open-Label Extension
PO:04:046 | Achieving Early Clinical Response was Associated with Cumulative Benefits on Disease Impact up to 2 Years in Patients with Active Psoriatic Arthritis Treated with Bimekizumab
PO:05:071 | Impact of age at onset on Spondyloarthritis clinical profile and quality of life: a monocentric cohort analysis
PO:06:081 | Safety of JAK inhibitors compared to non-TNF-targeted biologic therapies in rheumatoid arthritis patients who are inadequate responders to TNF inhibitors
PO:06:088 | Are all Difficult-To-Treat RA patients the same? Insights into clinical features and drug discontinuation
PO:08:124 | An exploratory analysis of risk factors for methotrexate-associated osteopathy: a retrospective study
PO:10:141 | A Case Study: Navigating the VEXAS Syndrome Mimickers
PO:10:144 | Management of pure red cell aplasia as the onset of systemic lupus erythematosus: a case report
PO:11:165 | Clinical mimicry and therapeutic challenge: A Case of Rapidly Progressive Mixed Connective Tissue Disease
PO:11:170 | When Paget Meets Inflammatory Back Pain: A Diagnostic Dilemma Between Bone Remodeling and Spondyloarthritis
PO:12:177 | Systemic inflammation and QTc interval prolongation in new-onset polymyalgia rheumatica: the effect of corticosteroid therapy
PO:12:179 | Cardiovascular outcomes of treat-to-target urate-lowering therapy in gout: emulated target trials
PO:12:183 | Acute effect of anti-TNF therapy on atrioventricular conduction in chronic inflammatory arthritis: a prospective cohort study
PO:12:184 | Atrioventricular conduction in chronic inflammatory arthritis: enhanced assessment by new electrocardiographic parameters
PO:12:187 | Maternal Hypertensive Disorders in Pregnant Women with Rheumatic Diseases and long-term Cardiovascular Outcomes: preliminary data of a single centre experience
PO:14:201 | Olfactory Assessment in Patients with Systemic Lupus Erythematosus: Correlation with Clinical, Serological, and Imaging Markers
PO:15:209 | Attainment of remission or lupus low disease activity state in single center Lupus Clinic
PO:16:234 | Differential efficacy of induction treatments for lupus nephritis at onset and relapses: an observational study
PO:16:240 | Systemic Lupus Erythematosus Presenting as End-Stage Liver Disease: A Case Report and Literature Review
PO:17:259 | Anifrolumab: a new management of SLE
EUVIMED